| Pten in stromal fibroblasts suppresses mammary epithelial tumours AJ Trimboli, CZ Cantemir-Stone, F Li, JA Wallace, A Merchant, N Creasap, ... Nature 461 (7267), 1084-1091, 2009 | 605 | 2009 |
| The nucleotide-binding site of bacterial translation initiation factor 2 (IF2) as a metabolic sensor P Milon, E Tischenko, J Tomšic, E Caserta, G Folkers, A La Teana, ... Proceedings of the National Academy of Sciences 103 (38), 13962-13967, 2006 | 206 | 2006 |
| Mapping the fMet-tRNAfMet binding site of initiation factor IF2 M Guenneugues, E Caserta, L Brandi, R Spurio, S Meunier, CL Pon, ... The EMBO journal 19 (19), 5233-5240, 2000 | 120 | 2000 |
| Initiation factors in the early events of mRNA translation in bacteria CO Gualerzi, L Brandi, E Caserta, C Garofalo, M Lammi, A LA TEANA, ... Cold Spring Harbor symposia on quantitative biology 66, 363-376, 2001 | 117 | 2001 |
| The C-terminal subdomain (IF2 C-2) contains the entire fMet-tRNA binding site of initiation factor IF2 R Spurio, L Brandi, E Caserta, CL Pon, CO Gualerzi, R Misselwitz, C Krafft, ... Journal of Biological Chemistry 275 (4), 2447-2454, 2000 | 87 | 2000 |
| Translation initiation factor IF2 interacts with the 30 S ribosomal subunit via two separate binding sites E Caserta, J Tomšic, R Spurio, A La Teana, CL Pon, CO Gualerzi Journal of molecular biology 362 (4), 787-799, 2006 | 83 | 2006 |
| Allele-specific tumor spectrum in pten knockin mice H Wang, M Karikomi, S Naidu, R Rajmohan, E Caserta, HZ Chen, ... Proceedings of the National Academy of Sciences 107 (11), 5142-5147, 2010 | 82 | 2010 |
| Ribosomal localization of translation initiation factor IF2 S Marzi, W Knight, L Brandi, E Caserta, N Soboleva, WE Hill, CO Gualerzi, ... Rna 9 (8), 958-969, 2003 | 80 | 2003 |
| Translation initiation in bacteria CO Gualerzi, L Brandi, E Caserta, A La Teana, R Spurio, J Tomšic, ... The ribosome: Structure, function, antibiotics, and cellular interactions …, 2000 | 71 | 2000 |
| Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma E Caserta, J Chea, M Minnix, EK Poku, D Viola, S Vonderfecht, P Yazaki, ... Blood, The Journal of the American Society of Hematology 131 (7), 741-745, 2018 | 67 | 2018 |
| Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting D Viola, A Dona, E Caserta, E Troadec, F Besi, T McDonald, L Ghoda, ... Leukemia 35 (1), 189-200, 2021 | 65 | 2021 |
| Daratumumab induces CD38 internalization and impairs myeloma cell adhesion J Ghose, D Viola, C Terrazas, E Caserta, E Troadec, J Khalife, EG Gunes, ... Oncoimmunology 7 (10), e1486948, 2018 | 52 | 2018 |
| HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide A Canella, HC Nieves, DW Sborov, L Cascione, HS Radomska, E Smith, ... Oncotarget 6 (31), 31134, 2015 | 46 | 2015 |
| Reolysin and histone deacetylase inhibition in the treatment of head and neck squamous cell carcinoma AC Jaime-Ramirez, JG Yu, E Caserta, JY Yoo, J Zhang, TJ Lee, ... Molecular Therapy-Oncolytics 5, 87-96, 2017 | 40 | 2017 |
| Histone deacetylase inhibitors enhance the therapeutic potential of reovirus in multiple myeloma A Stiff, E Caserta, DW Sborov, GJ Nuovo, X Mo, SY Schlotter, A Canella, ... Molecular cancer therapeutics 15 (5), 830-841, 2016 | 40 | 2016 |
| MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages J Khalife, J Ghose, M Martella, D Viola, A Rocci, E Troadec, C Terrazas, ... JCI insight 4 (21), 2019 | 36 | 2019 |
| Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo E Caserta, O Egriboz, H Wang, C Martin, C Koivisto, T Pecót, RD Kladney, ... Genes & development 29 (16), 1707-1720, 2015 | 31 | 2015 |
| Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64–labeled daratumumab A Krishnan, V Adhikarla, EK Poku, J Palmer, A Chaudhry, ... Blood Advances 4 (20), 5194-5202, 2020 | 30 | 2020 |
| CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma H Lewinsky, EG Gunes, K David, L Radomir, MP Kramer, B Pellegrino, ... JCI insight 6 (4), 2021 | 28 | 2021 |
| Comparison of CD38-targeted α-versus β-radionuclide therapy of disseminated multiple myeloma in an animal model M Minnix, V Adhikarla, E Caserta, E Poku, R Rockne, JE Shively, ... Journal of Nuclear Medicine 62 (6), 795-801, 2021 | 22 | 2021 |
